Growing community of inventors

Barcelona, Spain

Pier-Davide Angellini

Average Co-Inventor Count = 5.46

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 10

Pier-Davide AngelliniJosé Baselga Torres (4 patents)Pier-Davide AngelliniJoaquin Arribas Lopez (2 patents)Pier-Davide AngelliniKim Pedersen (2 patents)Pier-Davide AngelliniJosep Lluis Parra Palau (1 patent)Pier-Davide AngelliniJosep Liuis Parra Palau (1 patent)Pier-Davide AngelliniSirle Laos (1 patent)Pier-Davide AngelliniJoaquín Arribas López (0 patent)Pier-Davide AngelliniJosep Lluís Parra Palau (0 patent)Pier-Davide AngelliniJoaquín Arribas López (0 patent)Pier-Davide AngelliniJoaquín Arribas López (0 patent)Pier-Davide AngelliniPier-Davide Angellini (2 patents)José Baselga TorresJosé Baselga Torres (4 patents)Joaquin Arribas LopezJoaquin Arribas Lopez (2 patents)Kim PedersenKim Pedersen (2 patents)Josep Lluis Parra PalauJosep Lluis Parra Palau (1 patent)Josep Liuis Parra PalauJosep Liuis Parra Palau (1 patent)Sirle LaosSirle Laos (1 patent)Joaquín Arribas LópezJoaquín Arribas López (0 patent)Josep Lluís Parra PalauJosep Lluís Parra Palau (0 patent)Joaquín Arribas LópezJoaquín Arribas López (0 patent)Joaquín Arribas LópezJoaquín Arribas López (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Fundacio Privada Institut D'investigacio Oncologica De Vall Hebron (1 from 7 patents)

2. Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats (1 from 2 patents)

3. Fundacio Privada Institut D'investigacio Oncologica De Vall D'hebron (1 from 2 patents)

4. Fundacio Privada Institucio Catalana De Recera I Estudis Avancats (1 from 1 patent)

5. Fundació Privada Institut De Recerca Hospital Universitari Vall Hebron (1 from 1 patent)

6. Fundació Privada Institució Catalana De Recerca I Estudis Avançants (0 patent)


2 patents:

1. 8741586 - Antibodies against HER2 truncated variant CTF-611

2. 8389227 - Method for diagnosing cancers expressing the HER2 receptor or its truncated variants

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…